Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate ...

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

A quick look at the options chain for Moderna in mid-August shows a significant number of call options with a $30 stock price. That would be after the company’s earnings report on August 7, suggesting ...

Using CRISPR gene editing and stem cell-derived motor neurons, scientists from Stockholm University and UK Dementia Research ...

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK ...